[1]朱莉娜,王建华,李思萌,等.慢性肾脏病患者健康效用评估：四种量表的比较与影响因素分析[J].卫生经济研究,2024,41(12):50-54,59.
　ZHU Lina,WANG Jianhua,LI Simeng,et al.Assessment of Health Utility in Patients with Chronic Kidney Disease: Comparison of Four Scales and Analysis of Influencing Factors[J].Journal Press of Health Economics Research,2024,41(12):50-54,59.
点击复制

慢性肾脏病患者健康效用评估：四种量表的比较与影响因素分析
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年12期
页码:
50-54,59
栏目:
经济学评价
出版日期:
2024-12-03

文章信息/Info

Title:
Assessment of Health Utility in Patients with Chronic Kidney Disease: Comparison of Four Scales and Analysis of Influencing Factors
作者:
朱莉娜1; 王建华2; 3; 李思萌4; 张雅菲1; 王轶睿2; 3; 王钰博2; 3
1.新疆医科大学药学院，新疆 乌鲁木齐 830054
2.新疆医科大学第一附属医院，新疆 乌鲁木齐 830011
3.新疆药物临床研究重点实验室，新疆 乌鲁木齐 830011
4.中国药科大学国际医药商学院，江苏 南京 211198
Author(s):
ZHU Lina;  WANG Jianhua;  LI Simeng;  ZHANG Yafei;  WANG Yirui;  WANG Yubo
College of Pharmacy, Xinjiang Medical University, Urumqi Xinjiang 830054，China
关键词:
慢性肾脏病; 健康效用值; 量表; 影响因素
Keywords:
chronic kidney disease;  health utility value;  scales;  influencing factors
分类号:
R19
文献标志码:
A
摘要:
目的：以慢性肾脏病（CKD）患者为研究对象，比较EQ-VAS、EQ-5D-3L、EQ-5D-5L及SF-6D四种健康效用量表的相关性和差异性，分析患者健康效用值的影响因素。方法：采用方便抽样方法，获取患者资料，采用Tobit回归分析患者健康效用值的影响因素。结果：纳入145名慢性肾脏病患者进行健康效用分析，EQ-5D-3L量表测得的健康效用值中位数最高；EQ-5D量表两个版本的相关性和一致性最高，但存在天花板效应、信息区分能力差异，以及再分布不一致的情况；四个量表的健康效用影响因素不尽相同。结论：四个量表对健康效用的评价各有侧重，在临床实践中应综合考虑，选择合适患者的健康效用量表，并充分了解其特点和影响因素，以更好地评估患者的健康状态。
Abstract:
Objective Taking patients with chronic kidney disease(CKD) as the research object, to compare the correlation and differences in four health utility scales, EQ-VAS, EQ-5D-3L, EQ-5D-5L, and SF-6D, and to analyze the influencing factors of patients' health utility value. Methods Convenient sampling method was used to obtain patient data, and Tobit regression was used to analyze the influencing factors of patients' health utility value. Results A total of 145 patients with chronic kidney disease were included for health utility analysis, and the median health utility value measured by EQ-5D-3L scale was the highest. The two versions of EQ-5D scale had the highest correlation and consistency, but there were issues such as ceiling effects, differences in information discrimination capacity, and inconsistent redistribution. The influencing factors of health utility of the four scales were different. Conclusion The four scales have their own emphasis on the assessment of health utility. In clinical practice, it is important to comprehensively consider selecting appropriate health utility scales and fully understand their characteristics and influencing factors in order to better assess the health status of patients.

参考文献/References:

[1] 潘林蓉，刘爽，蒋更如.慢性肾脏病患者生活质量评估方法与影响因素的研究现状[J].中国血液净化，2020，19（01）49-51，55.
[2] Zhang Y,Li J,Yang L.Health-related quality of life of Chinese patients with chronic kidney disease:a study based on four EQ-5D-3L value sets[J].Scientific Reports,2023,13(01):7863.
[3] 卢钰琼，代展菁，路云，等.健康状态效用值测量研究报告规范及对比研究[J].卫生经济研究，2022，39（07）：68-73.
[4] 周挺，王子婧，孟蕊，等.普通人群应用欧洲五维健康量表与六维度健康调查简表测量健康效用值差异比较系统综述[J].中国药物经济学，2023，18（02）：18-25，30.
[5] Chen C,Liu G G,Shi Q L,et al.Health-related quality of life and associated factors among oldest-old in China[J].The Journal of Nutrition, Health & Aging,2020,24(03):330-338.
[6] 伍红艳. 健康效用值测量研究[D].沈阳：沈阳药科大学，2013.
[7] Zhu W,Zhang Y,Chen S,et al.Comparison of the applicability of seven calculation equations of glomerular filtration rate among elderly people in China[J].International Urology and Nephrology, 2024,56(07):2431-2440.
[8] Liu G G,Guan H,Jin X,et al.Rural population’s preferences matter:a value set for the EQ-5D-3L health states for China’s rural population[J].Health and Quality of Life Outcomes,2022,20(01):14.
[9] Luo N,Liu G,Li M,et al.Estimating an EQ-5D-5L value det for China[J].Value in Health:the Journal of the International Society for Pharmacoeconomics and Outcomes Research,2017,20(04):662-669.
[10] Wu J,Xie S,He X,et al.Valuation of SF-6Dv2 health States in China using time trade-off and discrete-choice experiment with a duration dimension[J].Pharmaco Economics,2021,39(05):521-535.
[11]周挺，官海静，刘国恩，等.基于中国普通人群的EQ-5D-3L与EQ-5D-5L比较研究[J].中国卫生经济，2016，35（03）：17-20.
[12] Vanstel H F,Buskens E.Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease[J].Health and Quality of Life Outcomes,2006(04):20.
[13] 张堂钦，伍红艳，蔡一凡，等.基于EQ-5D-5L和SF-6D量表的我国普通人群生命质量现状及影响因素研究[J].中国卫生事业管理，2020，37（08）：631-634.
[14] 杨相杰，周润哲，孟雨晴，等.腹膜透析患者健康相关生活质量及其影响因素分析[J].安徽医科大学学报，2024，59（01）：161-167.
[15] 孙禾奇，吕军，叶建明，等.血液透析和腹膜透析技术对患者生活质量的影响分析[J].中国卫生事业管理，2022，39（07）：552-555.
[16] Cheng L J,Pan T,Chen L A,et al.The ceiling effects of EQ-5D-3L and 5L in general population health surveys:a systematic review and meta-analysis[J].Value in Health:the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2024,27(07):986-997.
[17] Robinson B M,Akizawa T,Jager K J,et al.Factors affecting outcomes in patients reaching end-stage kidney disease worldwide:differences in access to renal replacement therapy,modality use,and haemodialysis practices[J].Lancet(London, England),2016, 388(10041):294-306.
[18] Manns B,Tonelli M,Yilmaz S,et al.Establishment and maintenance of vascular access in incident hemodialysis patients:a prospective cost analysis[J].Journal of the American Society of Nephrology: JASN,2005,16(01):201-209.

相似文献/References:

[1]吴洁琪,曹林林,孙利华.EQ-5D和SF-6D测量同期健康效用值的比较研究[J].卫生经济研究,2020,(02):42.
　WU Jie-qi,CAO Lin-lin,SUN Li-hua.Comparative Study of EQ-5D and SF-6D in Measuring Health Utility Value over the Same Period[J].Journal Press of Health Economics Research,2020,(12):42.

更新日期/Last Update: 2024-12-03